OCULAR HYPERTENSION
Clinical trials for OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drop shows promise in lowering glaucoma pressure
Disease control CompletedThis study tested a new eye drop called NCX 470 in 696 people with open-angle glaucoma or high eye pressure. Participants used the drop once daily for up to 12 months, and researchers measured how well it lowered eye pressure compared to a standard treatment, latanoprost. The goa…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Nicox Ophthalmics, Inc. • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
New eye drop shows promise for glaucoma in early trial
Disease control CompletedThis study tested a new eye drop called SBI-100 in 56 adults with glaucoma or high eye pressure. Participants used the drop twice daily for 14 days. Researchers measured how well it lowered eye pressure and checked for side effects. The goal is to find a safe and effective treatm…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Skye Bioscience, Inc. • Aim: Disease control
Last updated May 26, 2026 05:44 UTC
-
New lens implant fights glaucoma and cataracts at once!
Disease control CompletedThis study tested a special lens implant that slowly releases medication to lower eye pressure in people with cataracts and glaucoma or high eye pressure. 24 participants received the implant during cataract surgery and were followed for 6 months. The goal was to see if the impla…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated May 26, 2026 05:43 UTC
-
New eye drop shows promise in glaucoma battle
Disease control CompletedThis study tested two different strengths of a new eye drop called T4090 against an existing drop, Rhopressa, in 161 adults with open-angle glaucoma or high eye pressure. The goal was to see which one lowers eye pressure better and is safer. Participants used the drops for a set …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New eye drop shows promise for lowering pressure in glaucoma patients
Disease control CompletedThis study tested a new eye drop called Reformulated PG324 to see how safe and effective it is at lowering eye pressure in people with open-angle glaucoma or ocular hypertension. About 489 participants took part in this phase 3 trial. The main goal was to measure eye pressure at …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New eye drops show promise for glaucoma patients
Disease control CompletedThis study tested two new eye drops (AR-17043 and a combination with latanoprost) to see if they safely lower eye pressure in people with open-angle glaucoma or high eye pressure. A total of 426 adults took part. The goal was to find the best dose for reducing pressure, which is …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE2 • Sponsor: Alcon Research • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Smart contact lens could revolutionize glaucoma monitoring
Diagnosis CompletedThis study tested a new contact lens device that records eye pressure patterns over 24 hours in 86 adults with glaucoma and healthy volunteers. Participants wore the lens in one eye and took smartphone pictures every 15 minutes while awake. Researchers compared the lens readings …
Matched conditions: OCULAR HYPERTENSION
Sponsor: Smartlens, Inc. • Aim: Diagnosis
Last updated May 22, 2026 14:04 UTC